|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-8-29
|
|
pubmed:abstractText |
A fibrinolytic agent more effective than streptokinase available for bolus injection with reasonable cost-effectiveness is a desirable goal. Pilot studies with bolus pegulated staphylokinase (PEG-Sak) have revealed excellent Thrombolysis In Myocardial Infarction (TIMI) 3 60-minute flow.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
pubmed-author:AdgeyA A JAA,
pubmed-author:ArmstrongP WPW,
pubmed-author:BanZZ,
pubmed-author:BetriuAA,
pubmed-author:BodeCC,
pubmed-author:BurtonJJ,
pubmed-author:CAPTORS II Investigators,
pubmed-author:MolhoekP GPG,
pubmed-author:PakolaSS,
pubmed-author:TenderaMM,
pubmed-author:VahanianAA,
pubmed-author:Van de WerfFF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
146
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
484-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12947367-Adult,
pubmed-meshheading:12947367-Aged,
pubmed-meshheading:12947367-Analysis of Variance,
pubmed-meshheading:12947367-Female,
pubmed-meshheading:12947367-Fibrinolytic Agents,
pubmed-meshheading:12947367-Humans,
pubmed-meshheading:12947367-Male,
pubmed-meshheading:12947367-Metalloendopeptidases,
pubmed-meshheading:12947367-Middle Aged,
pubmed-meshheading:12947367-Myocardial Infarction,
pubmed-meshheading:12947367-Statistics, Nonparametric,
pubmed-meshheading:12947367-Streptokinase,
pubmed-meshheading:12947367-Thrombolytic Therapy,
pubmed-meshheading:12947367-Tissue Plasminogen Activator
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).
|
|
pubmed:affiliation |
University of Alberta, Edmonton, Alberta, Canada. paul.armstrong@ualberta.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
